In Re Sulzer Orthopedics Inc. Hip Prosthesis & Knee Prosthesis Products Liability Litigation

335 F. Supp. 2d 830, 2004 U.S. Dist. LEXIS 21982, 2004 WL 2091224
CourtDistrict Court, N.D. Ohio
DecidedAugust 25, 2004
Docket1:01-CV-9000. MDL NO. 1401, 1:03-CV-9007
StatusPublished
Cited by1 cases

This text of 335 F. Supp. 2d 830 (In Re Sulzer Orthopedics Inc. Hip Prosthesis & Knee Prosthesis Products Liability Litigation) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Sulzer Orthopedics Inc. Hip Prosthesis & Knee Prosthesis Products Liability Litigation, 335 F. Supp. 2d 830, 2004 U.S. Dist. LEXIS 21982, 2004 WL 2091224 (N.D. Ohio 2004).

Opinion

O’MALLEY, District Judge.

For the reasons stated below: (1) plaintiffs’ motion to amend the complaint (docket no. 10) is DENIED; (2) Sulzer’s motion to stay discovery (docket no. 13) is DENIED; and (8) Sulzer’s motion for summary judgment (docket no. 2338, in related case no. 01-CV-9000) is GRANTED. Accordingly, this case is DISMISSED.

I. Procedural History and Undisputed Facts.

The following facts are not in dispute. Plaintiff Norman Stahl was implanted with one of the “Affected Products” that are the subject of the Multi-District Litigation *832 pending before this Court in the case known as In Re: Sulzer Hip Prosthesis and Knee Prosthesis Liability Litigation, MDL No. 1401, Case No. 01-CV-9000. Specifically, Norman was implanted with an Inter-Op acetabular shell, which he later had removed pursuant to “revision surgery.” The In Re: Sulzer MDL case ultimately settled, with each plaintiff class member who underwent revision surgery to remove an “Affected Product” receiving at least $160,000.

Well before In Re: Sulzer finally settled, however, Norman and Betty Stahl reached their own, private settlement with Sulzer, and signed a release. In particular, on September 4, 2001, the Stahls and Sulzer entered into a written settlement agreement, which the Stahls’ attorney, Richard Carpenter, also signed (affirming he had “approved and witnessed” the Agreement). Among other terms, the parties’ settlement and release provided that Sulzer would: (1) pay the Stahls and their attorney $60,000; and (2) pay all subrogation claims brought by any insurer related to Norman’s revision surgery. Obviously, the Stahls’ private settlement with Sulzer provided them with less compensation than they might have obtained by participating in the class action settlement.

Just above the Stahls’ and their attorney Carpenter’s signatures, the Settlement Agreement sets out the following language:

INFORMED AND AUTHORIZED EXECUTION

[The Stahls] agree and represent that [they] have carefully considered settlement of the claims as described in this Release and that [they] desire to fully and finally compromise said claims for the consideration specified in this Release. [The Stahls] understand they are entitled to seek the advice of an attorney before signing this release.
[The Stahls] declare and represent that there have been no other inducements for this settlement and compromise other than the consideration specified in this Release. In executing this Release, [the Stahls] declare and represent that [they] have not been influenced to any extent by any representations made by [Sulzer], or by agents of or counsel for [Sulzer],

Agreement at 4. The Agreement also provided that, in consideration for the promised payments, the Stahls could not make any further claims against Sulzer arising out of the implantation of the Sulzer Inter-Op acetabular shell. Id. at 2.

Sulzer made the promised payments to the Stahls. Nonetheless, about one year later, after the Class Action Settlement was reached in the MDL, the Stahls submitted a claim for class action settlement benefits. The Claims Administrator rejected the Stahls’ class action claim, based on the Stahls’ prior, individual Settlement Agreement.

On April 11, 2003, after their claim for class action benefits was denied, the Stahls filed the instant case in Oklahoma state court, seeking to “set aside” their private settlement and release agreement with Sulzer. Sulzer removed the case to the United States District Court for the Northern District of Oklahoma, based on diversity jurisdiction. The Judicial Panel on Multi-District Litigation then transferred the case to this Court, as related to In Re: Sulzer. This Court earlier denied a motion by the Stahls to remand the case back to Oklahoma state court, premised on an insufficient amount in controversy to support diversity jurisdiction.

In this case, the Stahls advance a single claim: Sulzer “exercised undo [sic] advantage, misrepresentation, omission, and financial duress” during the negotiation of their private Settlement Agreement, so *833 that the Agreement should now be set aside. In their proposed amended complaint, the Stahls state with greater particularity the alleged misrepresentations by Sulzer during settlement negotiations. The Stahls’ critical allegations are that, during negotiation of the Settlement Agreement: (1) Sulzer “represented that it was at risk of failing to survive as a company in light of the financial demands that were being made against it as a result of implantation of defective devices in a great number of people”; (2) Sulzer further represented that financial failure would leave it unable to pay any claims to any claimants, including the Stahls; and (3) Sulzer made these representations about corporate survival “at a time when [Sulzer] knew that many financial sources were available to satisfy all claims against it.” Proposed amended complaint at 2.

Although the Stahls do not say so explicitly, if the Court finds their claim well-taken, they presumably would then return the $60,000 in private Settlement benefits earlier received and apply for the $160,000 in Class Action Settlement Benefits.

II.

Federal Rule of Civil Procedure 56(©) governs summary judgment motions and provides:

The judgment sought shall be rendered forthwith if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law ....

Rule 56(e) specifies the materials properly submitted in connection with a motion for summary judgment:

Supporting and opposing affidavits shall be made on personal knowledge, shall set forth such facts as would be admissible in evidence, and shall show affirmatively that the affiant is competent to testify to the matters stated therein .... The court may permit affidavits to be supplemented or opposed by depositions, answers to interrogatories, or further affidavits. When a motion for summary judgment is made and supported as provided in this rule, an adverse party may not rest upon the mere allegations or denial of the adverse party’s pleading, but the adverse party’s response, by affidavits or as otherwise provided in this rule, must set forth specific facts showing that there is a genuine issue for trial. If the adverse party does not so respond, summary judgment, if appropriate, shall be entered against the adverse party.

However, the movant is not required to file affidavits or other similar materials negating a claim on which its opponent bears the burden of proof, so long as the movant relies upon the absence of the essential element in the pleadings, depositions, answers to interrogatories, and admissions on file. Celotex Corp. v. Catrett,

Related

Howard v. Zimmer, Inc.
2013 OK 17 (Supreme Court of Oklahoma, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
335 F. Supp. 2d 830, 2004 U.S. Dist. LEXIS 21982, 2004 WL 2091224, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-sulzer-orthopedics-inc-hip-prosthesis-knee-prosthesis-products-ohnd-2004.